Business

Cipher Pharmaceuticals Schedules Q4 2022 Earnings Release and Conference Call

Cipher Pharmaceuticals Schedules Q4 2022 Earnings Release and Conference Call Canada Ne...

articleCipher Pharmaceuticals Inc.March 10, 20235/company/cipher-pharmaceuticals-inc/news/cipher-pharmaceuticals-schedules-q4-2022-earnings-release-and-conference-call
Cipher Pharmaceuticals Schedules Q4 2022 Earnings Release and Conference Call

About this update from Cipher Pharmaceuticals Inc.

[{"type":"text","content":"\n \n \n \n Cipher Pharmaceuticals Schedules Q4 2022 Earnings Release and Conference Call\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prngen2{\nPADDING-RIGHT:0.17em; PADDING-LEFT:0.17em; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT; BORDER-TOP:black 1pt; BORDER-RIGHT:black 1pt; BORDER-BOTTOM:black 1pt; BORDER-LEFT:black 1pt\n}\n.prnml4{\nMARGIN-TOP:0em; MARGIN-RIGHT:0em; MARGIN-BOTTOM:0em; MARGIN-LEFT:0.33em !IMPORTANT\n}\n.prnbcc{\nBORDER-COLLAPSE: COLLAPSE; BORDER-TOP:1pt black; BORDER-RIGHT:1pt black; BORDER-BOTTOM:1pt black; BORDER-LEFT:1pt black\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n \n MISSISSAUGA, ON\n \n \n ,\n \n \n March 10, 2023\n \n \n /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (\"\n \n Cipher\n \n \" or \"the\n \n Company\n \n \") today announced that it will release its financial results for the three and twelve months ended\n \n December 31, 2022\n \n after market close on\n \n March 16, 2023\n \n . The Company will also host a conference call on\n \n Friday, March 17, 2023\n \n at\n \n 8:30am ET\n \n to discuss the results and corporate developments.\n \n \n \n CONFERENCE CALL DETAILS\n \n \n \n \n \n \n \n \n DATE:\n \n \n \n \n \n \n Friday, March 17, 2023\n \n \n \n \n \n \n \n \n TIME:\n \n \n \n \n \n \n 8:30 a.m. EDT\n \n \n \n \n \n \n \n \n DIAL-IN NUMBER:\n \n \n \n \n \n \n (416) 764-8650 or (888) 664-6383\n \n \n \n \n \n \n \n \n CONFERENCE ID:\n \n \n \n \n \n \n 02194569\n \n \n \n \n \n \n \n \n REPLAY DIAL-IN:\n \n \n \n \n \n \n (888) 390-0541 (playback 194569#)\n \n \n \n \n \n \n \n \n \n \n \n Expires March 24, 2023\n \n \n \n \n \n \n \n \n WEBCAST:\n \n \n \n \n \n \n \n https://app.webinar.net/VDZxNRGzWPq\n \n \n \n \n \n \n \n \n \n \n \n About Cipher Pharmaceuticals Inc.\n \n \n \n Cipher Pharmaceuticals (TSX: CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products either ...

More updates from Cipher Pharmaceuticals Inc.